Hepatology

Individuals with NASH and significant liver fibrosis have a higher risk for serious liver-related outcomes compared with those with simple steatosis. Which endpoint should be a target for treatment: NASH...

An article was recently published about the key advancements and trends in gastroenterology and hepatology over the past decade. Do you agree with the authors’ choices? Take our poll to voice your opinion! ...

Have you treated patients with acute hepatic porphyria in your practice? Let us know your experience with this rare genetic disorder by taking the poll!